CSL Behring Medical Expert Portal is a global web portal designed for healthcare professionals (HCPs) outside the US who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available for your country. The medical and scientific information provided on this website is for informational purposes only and should not replace professional advice from a healthcare provider in your area. Product labels may vary from country to country. Please ensure to follow the applicable label for your country.
Disclaimer: Due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.
Disclaimer
Speakers: Günter Auerswald and Will Thomas
Günter Auerswald and Will Thomas, two of the authors of a recently published systematic literature review, discuss the reported outcomes of studies that investigated the safety and efficacy of plasma-derived von Willebrand Factor and Factor VIII concentrate (pdVWF/FVIII) in a ratio of 2.4:1 for on-demand treatment of bleeds in von Willebrand disease (VWD).